Augustine Lawlor's Net Worth
$89.4 Million
Who is Augustine Lawlor?
Augustine Lawlor has an estimated net worth of $89.4 Million. This is based on reported shares across multiple companies, which include PHARMATHENE, INC, CRITICAL THERAPEUTICS INC, ADVANCIS PHARMACEUTICAL CORP, ACTIVBIOTICS INC, TETRALOGIC PHARMACEUTICALS Corp, Radius Health, Inc., TREVENA INC, PROTEOSTASIS THERAPEUTICS, INC., THRESHOLD PHARMACEUTICALS INC, GLOBEIMMUNE INC, MEMORY PHARMACEUTICALS CORP, LEAP THERAPEUTICS, INC., Cardiovascular Systems Inc, CATALYST BIOSCIENCES, INC., and HUMAN GENOME SCIENCES INC.
SEC CIK
Augustine Lawlor's CIK is 0001262327
Past Insider Trading and Trends
2007 was Augustine Lawlor's most active year for acquiring shares with 15 total transactions. Augustine Lawlor's most active month to acquire stocks was the month of July. 2016 was Augustine Lawlor's most active year for disposing of shares, totalling 25 transactions. Augustine Lawlor's most active month to dispose stocks was the month of January. 2017 saw Augustine Lawlor paying a total of $6,436,524.37 for 2,462,417 shares, this is the most they've acquired in one year. In 2014 Augustine Lawlor cashed out on 26,062,394 shares for a total of $10,132,641.75, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TETRALOGIC PHARMACEUTICALS Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.59M |
$7.00 | $6,913,946.14 | 2.59M |
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Radius Health, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18 - Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PHARMATHENE, INC (ALT) Snapshot price: $10.345
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +28.21% | 935.81K |
$2.54 | $2,378,558.44 | 4.25M |
Nov 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4/A
| +2,553.79% | 3.19M |
$7.66 | $957,500.00 | 3.32M |
Aug 3
| |||
Form 4
| +2,537.74% | 3.17M |
$7.66 | $957,500.00 | 3.3M |
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
TREVENA INC (TRVN) Snapshot price: $0.577
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.45M |
$7.00 | $2,079,406.00 | 2.45M |
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PROTEOSTASIS THERAPEUTICS, INC. (KA) Snapshot price: $2.66
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.15M |
$8.00 |
—
| 2.15M |
Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |